PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 15, 2003Journal of Clinical Investigation302 citations

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

View Full Paper
JMJens MogensenTKToru KuboMDMauricio Duque

Structured PICO

Are TNNI3 mutations associated with the clinical expression of idiopathic restrictive cardiomyopathy?

P
Population
A large family with individuals affected by either idiopathic restrictive cardiomyopathy (RCM) or hypertrophic cardiomyopathy (HCM), and 9 unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness.
I
Intervention
Genetic linkage and mutation analysis of the cardiac troponin I (TNNI3) gene
O
Outcome
Presence of TNNI3 mutationssurrogate

Mutations in the cardiac troponin I (TNNI3) gene are a significant genetic cause of idiopathic restrictive cardiomyopathy.

Abstract

Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by impaired filling of the ventricles with reduced volume in the presence of normal or near normal wall thickness and systolic function. The disease may be associated with systemic disease but is most often idiopathic. We recognized a large family in which individuals were affected by either idiopathic RCM or hypertrophic cardiomyopathy (HCM). Linkage analysis to selected sarcomeric contractile protein genes identified cardiac troponin I (TNNI3) as the likely disease gene. Subsequent mutation analysis revealed a novel missense mutation, which cosegregated with the disease in the family (lod score: 4.8). To determine if idiopathic RCM is part of the clinical expression of TNNI3 mutations, genetic investigations of the gene were performed in an additional nine unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness. TNNI3 mutations were identified in six of these nine RCM patients. Two of the mutations identified in young individuals were de novo mutations. All mutations appeared in conserved and functionally important domains of the gene.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mogensen et al. (2003) studied this question.

synapsesocial.com/papers/69ffc1ceb124fe5819859afdhttps://doi.org/10.1172/jci200316336
Ask AI
Helpful
Bookmark
Share
View Full Paper